The effect of lipoprotein lipase (LPL) polymorphism on plasma LPL concentration and triglyceride

National Medical Journal of China

Volumn 85, Issue 19, 2005, Pages 1339-1343

  Liu, Jun ^a   Zhao, Dong ^a   Liu, Jing ^a   Liu, Sa ^a   Qin, Lan Ping ^a   Wu, Zhao Su ^a  

^a BEIJING INSTITUTE OF HEART   (China)

Author keywords

Lipoprotein lipase; Polymorphism, restriction fragment length; Triglycerides

Indexed keywords

LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BODY MASS; CHINA; ENZYME BLOOD LEVEL; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; MULTIVARIATE ANALYSIS; OBESITY; PREVALENCE; PROTEIN DETERMINATION; SMOKING; WAIST CIRCUMFERENCE;

BODY MASS INDEX; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE; QUESTIONNAIRES; SAMPLING STUDIES; SMOKING; TRIGLYCERIDES;

EID: 20744447793     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Assmann G, Schulte H. Role of triglycerides in coronary disease: lessons from the Prospective Cardiovascular Muenster Study. Am J Cardiol, 1992, 70:10H-13H.
2. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease(The PROCAM experience). Am J Cardiol, 1992, 70: 733-737.
3. Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol, 1992, 70:3H-9H.
4. Expert panel on detection. Evaluation, and treatment of high blood cholesterol in adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel III). JAMA, 2001, 285: 2486-2497.
5. World Health Organization. Multination monitoring of treads and determinants in cardiovascular disease (MONICA project) and manual of operation. Cardiovascular Disease Unit, Geneva, 1993.
6. Wang KQ. Lipoprotein and atherosclerosis. 1rst. Beijing: People's Medical Publishing House, 1995.
7. Pei L, Wang SW, Ye P. Association of coronary artery disease with Lipoprotein Lipase Gene Polymorphisms. Natl Med J China, 1996, 76:547-548.
8. Xiang YG, Ni PH, Chen MS. Association of Lipoprotein Lipase Gene Hind III Polymorphisms with coronary artery disease and lipid. Chin J Clin Lab Sci, 2002, 20:42-44.
9. Shen H, Yu S, Xu Y, et al. DNA polymorphism of Pvu II site in the lipoprotein lipase gene in patients with type 2 diabetes mellitus. Chin J Med Genet, 2000, 17:24-27.
10. Anderson J, King G, Bair TL, et al. Association of Lipoprotein lipase Gene Polymorphisms with coronary artery disease. J Coll Cardiol, 1999, 33:1013-1020.
11. Humphries S E, Nicaud V, Margalef J, et al. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: The European Atherosclerosis ResearchStudy(EARS). Arterioscler Thromb Vasc Biol, 1998, 18:526-534.
12. Elisabet V, Jorge J, Mar F, et al. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins. J Lipid Rese, 1993, 34:1555-1564.
13. Wtanabe H, Mijashita Y, Murano T, et al. Preheparin serum lipoprotein lipase mass level: the effects of age, gender, and types of hyperlipidemias. Atherosclerosis, 1999, 145:45-50.
14. Kazunori S, Ikunosuke S, Mitsuhisa M. Serum lipoprotein lipase in healthy subjects: effects of gender and age, and relationships to lipid parameters. Ann Clin Biochem, 1998, 35:733-738.
15. Ko YL, Mj YS, Wu SM, et al. Interaction between obeity and genetic polymorphisms in the apolipoprotein CIII gene and LPL gene on the risk of hypertriglycerdemia in China. Hum Genet, 1997, 100:327.